Logo image of XHR

XENIA HOTELS & RESORTS INC (XHR) Stock Fundamental Analysis

NYSE:XHR - New York Stock Exchange, Inc. - US9840171030 - REIT - Currency: USD

12.28  +0.07 (+0.57%)

After market: 12.28 0 (0%)

Fundamental Rating

4

Taking everything into account, XHR scores 4 out of 10 in our fundamental rating. XHR was compared to 129 industry peers in the Diversified REITs industry. The financial health of XHR is average, but there are quite some concerns on its profitability. XHR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

XHR had positive earnings in the past year.
XHR had a positive operating cash flow in the past year.
In multiple years XHR reported negative net income over the last 5 years.
XHR had a positive operating cash flow in 4 of the past 5 years.
XHR Yearly Net Income VS EBIT VS OCF VS FCFXHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

XHR's Return On Assets of 0.79% is in line compared to the rest of the industry. XHR outperforms 53.49% of its industry peers.
With a Return On Equity value of 1.88%, XHR perfoms like the industry average, outperforming 51.94% of the companies in the same industry.
XHR has a Return On Invested Capital of 2.70%. This is comparable to the rest of the industry: XHR outperforms 48.84% of its industry peers.
The Average Return On Invested Capital over the past 3 years for XHR is in line with the industry average of 3.15%.
Industry RankSector Rank
ROA 0.79%
ROE 1.88%
ROIC 2.7%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
XHR Yearly ROA, ROE, ROICXHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With a Profit Margin value of 2.15%, XHR perfoms like the industry average, outperforming 45.74% of the companies in the same industry.
In the last couple of years the Profit Margin of XHR has declined.
Looking at the Operating Margin, with a value of 8.84%, XHR is doing worse than 80.62% of the companies in the same industry.
XHR's Operating Margin has declined in the last couple of years.
XHR's Gross Margin of 54.48% is on the low side compared to the rest of the industry. XHR is outperformed by 74.42% of its industry peers.
In the last couple of years the Gross Margin of XHR has remained more or less at the same level.
Industry RankSector Rank
OM 8.84%
PM (TTM) 2.15%
GM 54.48%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
XHR Yearly Profit, Operating, Gross MarginsXHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

XHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for XHR has been reduced compared to 1 year ago.
The number of shares outstanding for XHR has been reduced compared to 5 years ago.
Compared to 1 year ago, XHR has an improved debt to assets ratio.
XHR Yearly Shares OutstandingXHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
XHR Yearly Total Debt VS Total AssetsXHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.58, we must say that XHR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.58, XHR is in line with its industry, outperforming 51.94% of the companies in the same industry.
XHR has a debt to FCF ratio of 49.38. This is a negative value and a sign of low solvency as XHR would need 49.38 years to pay back of all of its debts.
XHR has a better Debt to FCF ratio (49.38) than 64.34% of its industry peers.
A Debt/Equity ratio of 1.17 is on the high side and indicates that XHR has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.17, XHR is in line with its industry, outperforming 53.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 49.38
Altman-Z 0.58
ROIC/WACC0.31
WACC8.73%
XHR Yearly LT Debt VS Equity VS FCFXHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.02 indicates that XHR should not have too much problems paying its short term obligations.
With a Current ratio value of 1.02, XHR perfoms like the industry average, outperforming 54.26% of the companies in the same industry.
A Quick Ratio of 1.02 indicates that XHR should not have too much problems paying its short term obligations.
XHR's Quick ratio of 1.02 is in line compared to the rest of the industry. XHR outperforms 55.04% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
XHR Yearly Current Assets VS Current LiabilitesXHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

XHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.79%, which is quite good.
XHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.70% yearly.
Looking at the last year, XHR shows a small growth in Revenue. The Revenue has grown by 3.57% in the last year.
Measured over the past years, XHR shows a decrease in Revenue. The Revenue has been decreasing by -1.99% on average per year.
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%87.5%
Revenue 1Y (TTM)3.57%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%8.01%

3.2 Future

The Earnings Per Share is expected to grow by 42.53% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.17% on average over the next years.
EPS Next Y243.4%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue Next Year2.19%
Revenue Next 2Y2.72%
Revenue Next 3Y3.17%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XHR Yearly Revenue VS EstimatesXHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
XHR Yearly EPS VS EstimatesXHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 55.82, which means the current valuation is very expensive for XHR.
XHR's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.34, XHR is valued quite expensively.
XHR is valuated quite expensively with a Price/Forward Earnings ratio of 43.74.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XHR indicates a somewhat cheap valuation: XHR is cheaper than 62.02% of the companies listed in the same industry.
XHR is valuated expensively when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 55.82
Fwd PE 43.74
XHR Price Earnings VS Forward Price EarningsXHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

74.42% of the companies in the same industry are more expensive than XHR, based on the Enterprise Value to EBITDA ratio.
XHR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. XHR is cheaper than 64.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.03
EV/EBITDA 11.28
XHR Per share dataXHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XHR's earnings are expected to grow with 42.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y36.82%
EPS Next 3Y42.53%

4

5. Dividend

5.1 Amount

XHR has a Yearly Dividend Yield of 4.22%, which is a nice return.
Compared to an average industry Dividend Yield of 6.77, XHR is paying slightly less dividend.
XHR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 4.22%

5.2 History

The dividend of XHR decreases each year by -15.89%.
XHR has been paying a dividend for at least 10 years, so it has a reliable track record.
XHR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-15.89%
Div Incr Years2
Div Non Decr Years2
XHR Yearly Dividends per shareXHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

XHR pays out 166.74% of its income as dividend. This is not a sustainable payout ratio.
DP166.74%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
XHR Yearly Income VS Free CF VS DividendXHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
XHR Dividend Payout.XHR Dividend Payout, showing the Payout Ratio.XHR Dividend Payout.PayoutRetained Earnings

XENIA HOTELS & RESORTS INC

NYSE:XHR (6/18/2025, 8:04:00 PM)

After market: 12.28 0 (0%)

12.28

+0.07 (+0.57%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners98.07%
Inst Owner Change-0.14%
Ins Owners0.94%
Ins Owner Change0.04%
Market Cap1.21B
Analysts78
Price Target13.87 (12.95%)
Short Float %3.63%
Short Ratio3.61
Dividend
Industry RankSector Rank
Dividend Yield 4.22%
Yearly Dividend0.47
Dividend Growth(5Y)-15.89%
DP166.74%
Div Incr Years2
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.14)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.68%
Min EPS beat(2)-199.01%
Max EPS beat(2)163.65%
EPS beat(4)3
Avg EPS beat(4)3.8%
Min EPS beat(4)-199.01%
Max EPS beat(4)163.65%
EPS beat(8)5
Avg EPS beat(8)60.16%
EPS beat(12)7
Avg EPS beat(12)107.12%
EPS beat(16)9
Avg EPS beat(16)83.21%
Revenue beat(2)1
Avg Revenue beat(2)1.13%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)3.88%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.98%
Max Revenue beat(4)3.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.46%
Revenue beat(12)5
Avg Revenue beat(12)0.59%
Revenue beat(16)9
Avg Revenue beat(16)1.91%
PT rev (1m)7.37%
PT rev (3m)-15.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)296.55%
EPS NY rev (1m)0%
EPS NY rev (3m)70%
Revenue NQ rev (1m)0.43%
Revenue NQ rev (3m)-4.99%
Revenue NY rev (1m)0.66%
Revenue NY rev (3m)-2.28%
Valuation
Industry RankSector Rank
PE 55.82
Fwd PE 43.74
P/S 1.14
P/FCF 42.03
P/OCF 6.26
P/B 1
P/tB 1.01
EV/EBITDA 11.28
EPS(TTM)0.22
EY1.79%
EPS(NY)0.28
Fwd EY2.29%
FCF(TTM)0.29
FCFY2.38%
OCF(TTM)1.96
OCFY15.99%
SpS10.74
BVpS12.25
TBVpS12.2
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 1.88%
ROCE 3.41%
ROIC 2.7%
ROICexc 2.81%
ROICexgc 2.86%
OM 8.84%
PM (TTM) 2.15%
GM 54.48%
FCFM 2.72%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
ROICexc(3y)2.94%
ROICexc(5y)N/A
ROICexgc(3y)2.99%
ROICexgc(5y)N/A
ROCE(3y)3.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.42%
ROICexc growth 3YN/A
ROICexc growth 5Y-6.41%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 49.38
Debt/EBITDA 6.35
Cap/Depr 126.88%
Cap/Sales 15.55%
Interest Coverage 1.29
Cash Conversion 86.6%
Profit Quality 126.64%
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 0.58
F-Score6
WACC8.73%
ROIC/WACC0.31
Cap/Depr(3y)167.19%
Cap/Depr(5y)114.68%
Cap/Sales(3y)21.77%
Cap/Sales(5y)17.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%87.5%
EPS Next Y243.4%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue 1Y (TTM)3.57%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%8.01%
Revenue Next Year2.19%
Revenue Next 2Y2.72%
Revenue Next 3Y3.17%
Revenue Next 5YN/A
EBIT growth 1Y3.25%
EBIT growth 3YN/A
EBIT growth 5Y-8.94%
EBIT Next Year188.72%
EBIT Next 3Y48.07%
EBIT Next 5YN/A
FCF growth 1Y-73.85%
FCF growth 3Y37.05%
FCF growth 5YN/A
OCF growth 1Y4.85%
OCF growth 3Y58.91%
OCF growth 5Y-7.87%